Yuki Kageyama to Uroplakin III
This is a "connection" page, showing publications Yuki Kageyama has written about Uroplakin III.
Connection Strength
0.031
-
Loss of uroplakin III expression is associated with a poor prognosis in patients with urothelial carcinoma of the upper urinary tract. BJU Int. 2006 Jun; 97(6):1322-6.
Score: 0.017
-
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003 Nov 15; 9(15):5501-7.
Score: 0.014